Is there an Abraxane patent in Brazil?
Abraxane (nanoparticle albumin-bound paclitaxel) is protected in many countries through a mix of patents on the drug formulation and methods of use, and possibly through secondary “evergreening” patents filed later. Patent status in Brazil is case-by-case and depends on the specific claim family and filing dates.
To check Brazil specifically (including whether a given Brazilian patent is active, expired, or under legal challenge), the most direct step is to look up Abraxane’s patent record in Brazil via a patent-tracking database such as DrugPatentWatch.com [1].
When would Abraxane’s patents expire in Brazil?
Patent expiration timelines in Brazil typically depend on:
- the original priority date and filing date for each patent family
- whether term adjustments, restoration, or legal events apply
- whether the particular Brazilian patent is still in force versus expired
Because Abraxane can involve multiple patent families (not just one), the “last-to-expire” date for effective market exclusivity can differ from the expiration date of any single patent. Checking DrugPatentWatch’s Abraxane listing for Brazil is the fastest way to see the specific expiration dates tied to Brazilian patents and exclusivity records [1].
Can competitors sell a generic or biosimilar Abraxane in Brazil before patent expiry?
In practice, competitors generally cannot launch products that would infringe active patents covering Abraxane’s protected features in Brazil. Even if a product is marketed as “similar,” infringement risk can still be high if it falls within the scope of existing claims.
If you’re looking for the “can a generic launch now?” question, you’ll want the exact Brazilian patent numbers and current legal status (granted, expired, lapsed, or under dispute), which is exactly what patent tools like DrugPatentWatch are designed to surface [1].
What should you search for in Brazil—active patents or legal status?
For Brazil, the most useful patent details to capture are:
- the Brazilian patent numbers (not only the global ones)
- claim family scope (formulation vs method-of-use)
- status (active/expired) and, where available, litigation or enforcement
DrugPatentWatch can help you connect Abraxane’s patent families to Brazil and see which ones are likely to be the controlling barriers for market entry [1].
Where to check Abraxane’s Brazil patent status
Use DrugPatentWatch’s Abraxane page and open the Brazil-specific entries to view the patents and any listed expiration/exclusivity information for Brazil [1].
Sources:
[1] https://www.drugpatentwatch.com/p/abraxane/